CLINICAL LABORATORY BUSINESS PLAN

I. Executive Summary

Company Description

Company name: name withheld by request; the name reflects clinical precision and rapid decision-making. We operate in the US clinical diagnostics sector as a CLIA-certified laboratory launching in 2026. Our core service is rapid, high-accuracy diagnostic testing delivered to private practices, specialty clinics, and urgent care centers. We combine advanced laboratory automation and robotics with a personalized client-services team so clinicians get actionable results fast.

Short-term goals: complete 2026 launch, validate core test menu, and serve regional outpatient providers. Long-term goals: expand service footprint, broaden test offerings, and embed into physician workflows to improve patient outcomes. Differentiators: sub-24-hour turnaround on routine panels, high-throughput automation for consistency, and a dedicated client success team for onboarding and physician support.

Problem

Healthcare providers experience slow diagnostic turnaround from large national laboratories, which causes delays in critical clinical decisions and treatment adjustments. Communication gaps between clinics and these labs further slow referrals and care coordination, increasing administrative burden and clinician frustration.

Private medical practices, specialty clinics, and urgent care centers lack laboratory partners that combine rapid, precise testing with high-touch, personalized client service. The current market also lacks seamless digital test-ordering integration, which raises error risk and consumes staff time.

One-liner: Slow lab turnaround and poor clinic–lab communication delay patient care.

Solution

Healthcare providers face slow, impersonal diagnostics from large national labs that delay treatment and create communication errors. We operate a state-of-the-art clinical laboratory in the United States that delivers rapid, reliable same-day diagnostic results and a dedicated support team to integrate with clinic workflows.

We provide comprehensive chemistry, hematology, and microbiology testing, 24/7 secure ordering and results access, robotics-driven processing for accuracy, and a paired client support team—so physicians can order after a visit and often adjust treatment the same day.

Mission Statement

Our mission is to deliver accurate, rapid, and reliable diagnostic data to private practices and specialty clinics through technological excellence and personalized service. We commit to the highest standards of clinical precision and regulatory compliance so providers can make timely, life‑saving decisions. We exist to empower the medical community with clear, actionable results that improve patient outcomes every day.

Key Success Factors

These factors drive operational speed, quality, retention, and financial scalability.

• Advanced laboratory automation enabling industry‑leading turnaround times.
• Dedicated client support model that secures high retention and strong professional relationships.
• Proprietary digital platform with seamless EHR integration and user‑friendly access.
• Highly skilled clinical team of Pathologists and Lab Scientists ensuring diagnostic quality.
• Rapid breakeven and strong EBITDA growth demonstrating a scalable financial model.

Financial Summary

Concise financial snapshot: launch in 2026, breakeven in the first month, fast payback and strong EBITDA growth.

Financial requirements: minimum cash $176,000 (required Mar-26). Performance highlights: breakeven Jan-26 (month 1), payback 11 months, fee-for-service pricing (chemistry $45; molecular $180), EBITDA Y1 $1,741,000 and EBITDA Y5 $24,985,000.

Overall outlook: high-margin, rapid-payback clinical lab with strong projected EBITDA growth.

Funding Requirements

The project requires $1,361,000 to fund capital build-out and maintain a minimum cash reserve for the 2026 launch.